𝔖 Bobbio Scriptorium
✦   LIBER   ✦

82 Recurrent Hepatocellular Carcinoma After Liver Transplantation in the MELD Era

✍ Scribed by Reddy, Chakradhar M.; Levi, David M.; Skartsis, Nikolaos; Ghanta, Ravi; Martin, Paul; Tzakis, Andreas G.; Selvaggi, Gennaro; Island, Eddie; Tekin, Akin; Nishida, Seigo; Moon, Jang

Book ID
122672634
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
44 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma: The MELD impact
✍ Pratima Sharma; Vijayan Balan; Jose L. Hernandez; Ann M. Harper; Erick B. Edward πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end-stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation. The aim of this study was to de

Late Recurrence of Hepatocellular Carcin
Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
✍ Kenneth S. H. Chok; See Ching Chan; Tan To Cheung; Albert C. Y. Chan; Sheung Tat πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 246 KB

## Background Long-term survival of patients with hepatocellular carcinoma (HCC) after liver transplantation is affected mainly by recurrence of HCC. There is the opinion that the chance of recurrence after 2Β years post-transplantation is remote, and therefore lifelong surveillance is not justified